Ketogenic diet along with high-dose ascorbic acid in triple-negative breast cancer
Phase 3
Recruiting
- Conditions
- Triple negative breast cancer.Malignant neoplasm of breast
- Registration Number
- IRCT20161022030424N11
- Lead Sponsor
- Tabriz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 240
Inclusion Criteria
18 to 70 years old
Pathologically confirmed early-stage triple-negative breast cancer subtype
1–3 positive axillary lymph nodes
Histological grades I-III
Unilateral cancer
A body mass index (BMI) of 25 kg/m2 and higher
Exclusion Criteria
Serious cardiovascular disease
Pregnancy
Cognitive impairment
Metabolic defects as a contraindication against ketogenic diet
Who are considered unsuitable for the trial by the principal investigator because of abnormal blood indices or other reasons
Use of systemic corticosteroids within one week of trial entry
Receipt of chemotherapy within two week of trial entry
Prior monoclonal antibody therapy within 1 month of trial entry
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method